From the ANN:
"The Company is confident in the relationship between raised cortisol and cognitive impairment."
But a problem arises if the raised cortisol is only a side-effect of some other as yet unknown process, and if Xanamem doesn't accidentally prevent that other process.
This issue has been raised by @US10.
Ann: Phase II Alzheimer's Disease Trial - results, page-30
-
- There are more pages in this discussion • 426 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
0.001(3.85%) |
Mkt cap ! $79.51M | |||
| Open | High | Low | Value | Volume |
| 2.7¢ | 2.8¢ | 2.7¢ | $224.5K | 8.316M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 2785949 | 2.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.7¢ | 2741224 | 4 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| ACW (ASX) Chart |